Paediatric Ophthalmologist and Epidemiologist Professor Jugnoo Rahi appointed NIHR Senior Investigator

26 Feb 2018, 4:04 p.m.

Professor Jugnoo Rahi

Professor Jugnoo Rahi has been appointed as National Institute for Health Research (NIHR) Senior Investigator in the eleventh annual competition.Jugnoo is Professor of Ophthalmic Epidemiology at the UCL Great Ormond Street Institute of Child Health (ICH) and UCL Institute of Ophthalmology and is supported by both the NIHR GOSH Biomedical Research Centre (BRC) and the NIHR Moorfields BRC. She is an Honorary Consultant Ophthalmologist at Great Ormond Street Hospital (GOSH).

NIHR Senior Investigators include some of the country’s foremost researchers who make a major contribution to clinical and applied health and social care research. Jugnoo is the first Paediatric Ophthalmologist to be honoured with an NIHR Senior Investigator award.

Her research focusses on understanding eye conditions that affect children or start in in childhood in order to improve prevention, treatment or rehabilitation and thus minimise risk of blindness. As well as playing a key role as advisor to the Public Health England’s National Screening Committee recent major review of universal vision screening for children, Jugnoo is leading the British Childhood Visual Impairment and Blindness Study 2, which will provide crucial information about childhood visual disability that will inform public health and clinical policies and services.

Commenting on her recent appointment Jugnoo Rahi, “I’m delighted to have been honoured with a prestigious NIHR Senior Investigator award, which puts a spotlight on my clinical sub-specialty of Paediatric Ophthalmology and my academic discipline of Ophthalmic Epidemiology. The support will enable more research into childhood eye conditions which will in turn influence visual health policy and NHS ophthalmology services”.

Professor Rahi is one of 34 researchers appointed as part of the 2018 competition and joins eight other GOSH and ICH researchers as part of the NIHR Senior Investigator faculty.

More information about the NIHR.
More information about the NIHR Senior Investigators.

This report presents independent research funded by the National Institute for Health Research (NIHR) (and Health Education England if applicable). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. 

Young people donate tissue samples to unlock mysteries of arthritis

A new groundbreaking study led by researchers at the University of Birmingham, Great Ormond Street Hospital, University College London and Birmingham Children’s Hospital has revealed important clues into what is driving arthritis in children.

Toddler doing well after receiving newest gene therapy available on NHS

A toddler with a life-limiting and life-threatening rare disease is the youngest to be treated with the newest gene therapy available on the NHS at GOSH.

Genes may help to predict which children will respond well to arthritis treatment

A team of researchers at Great Ormond Street Hospital (GOSH) and University College London (UCL) have identified a set of genes that could be used to help doctors predict which children will respond well to treatment for juvenile idiopathic arthritis.

Making it easier to invest in frontline care

GOSH and UCL have signed a landmark agreement to simplify the commercialisation of any joint research and innovation and ensure any financial proceeds are shared equally.